{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T05:10:50Z","timestamp":1769577050065,"version":"3.49.0"},"reference-count":99,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T00:00:00Z","timestamp":1593475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.01321","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T04:49:48Z","timestamp":1593492588000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Associations Between Plasma Immunomodulatory and Inflammatory Mediators With VACS Index Scores Among Older HIV-Infected Adults on Antiretroviral Therapy"],"prefix":"10.3389","volume":"11","author":[{"given":"Thomas A.","family":"Premeaux","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shireen","family":"Javandel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalei R. J.","family":"Hosaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meredith","family":"Greene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Therrien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel E.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Corley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor G.","family":"Valcour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lishomwa C.","family":"Ndhlovu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,6,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.immuni.2013.10.001","article-title":"Systemic effects of inflammation on health during chronic HIV infection","volume":"39","author":"Deeks","year":"2013","journal-title":"Immunity."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1212\/WNL.0b013e318200d727","article-title":"HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER study","volume":"75","author":"Heaton","year":"2010","journal-title":"Neurology."},{"key":"B3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11904-010-0041-9","article-title":"HIV and aging: time for a new paradigm","volume":"7","author":"Justice","year":"2010","journal-title":"Curr HIV\/AIDS Rep."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1056\/NEJMp1113643","article-title":"HIV and aging\u2013preparing for the challenges ahead","volume":"366","author":"Mills","year":"2012","journal-title":"N Engl J Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1089\/aid.2019.0130","article-title":"Harvard HIV and aging workshop: perspectives and priorities from Claude D. Pepper Centers and Centers for AIDS Research","volume":"35","author":"Montano","year":"2019","journal-title":"AIDS Res Hum Retroviruses."},{"key":"B6","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/QAI.0000000000000556","article-title":"Geriatric syndromes in older HIV-infected adults","volume":"69","author":"Greene","year":"2015","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12877-018-0789-0","article-title":"The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65\u201474 years and more than 75 years","volume":"18","author":"Guaraldi","year":"2018","journal-title":"BMC Geriatr."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1097\/QAD.0000000000000408","article-title":"The importance of monocytes and macrophages in HIV pathogenesis, treatment, and cure","volume":"28","author":"Campbell","year":"2014","journal-title":"AIDS."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/QAI.0000000000001554","article-title":"Inflammation-related morbidity and mortality among HIV-positive adults: how extensive is it?","volume":"77","author":"Hart","year":"2018","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B10","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1093\/infdis\/jiw275","article-title":"Immunologic biomarkers, morbidity, and mortality in treated HIV infection","volume":"214","author":"Hunt","year":"2016","journal-title":"J Infect Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1093\/infdis\/jiu275","article-title":"Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infection","volume":"210","author":"Wilson","year":"2014","journal-title":"J Infect Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1097\/QAD.0000000000000807","article-title":"Association of immune-activation and senescence markers with non-AIDS-defining comorbidities in HIV-suppressed patients","volume":"29","author":"Duffau","year":"2015","journal-title":"AIDS."},{"key":"B13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s11904-009-0038-4","article-title":"Early immune senescence in HIV disease","volume":"7","author":"Desai","year":"2010","journal-title":"Curr HIV\/AIDS Rep."},{"key":"B14","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/COH.0000000000000240","article-title":"Immune activation and immune aging in HIV infection","volume":"11","author":"Appay","year":"2016","journal-title":"Curr Opin HIV AIDS."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e0144312","DOI":"10.1371\/journal.pone.0144312","article-title":"Elevated biomarkers of inflammation and coagulation in patients with HIV are associated with higher framingham and VACS risk index scores","volume":"10","author":"Mooney","year":"2015","journal-title":"PLoS ONE."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1097\/QAD.0000000000001875","article-title":"Multimorbidity, age-related comorbidities and mortality: association of activation, senescence and inflammation markers in HIV adults","volume":"32","author":"Duffau","year":"2018","journal-title":"AIDS."},{"key":"B17","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/QAD.0b013e32835b8c7f","article-title":"An internationally generalizable risk index for mortality after 1 year of antiretroviral therapy","volume":"27","author":"Tate","year":"2013","journal-title":"AIDS."},{"key":"B18","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/QAI.0000000000000045","article-title":"The VACS index predicts mortality in a young, healthy HIV population starting highly active antiretroviral therapy","volume":"65","author":"Bebu","year":"2014","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B19","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/QAI.0b013e31827df36c","article-title":"Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: a North American cross cohort analysis","volume":"62","author":"Justice","year":"2013","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B20","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1089\/aid.2015.0012","article-title":"Short communication: SCD14 and SCD163 levels are correlated with VACS index scores: initial data from the Blunted Immune Recovery in CORE Patients with HIV (BIRCH) Cohort","volume":"32","author":"Williams","year":"2016","journal-title":"AIDS Res Hum Retroviruses."},{"key":"B21","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1093\/cid\/cir989","article-title":"Does an index composed of clinical data reflect effects of inflammation, coagulation, and monocyte activation on mortality among those aging with HIV?","volume":"54","author":"Justice","year":"2012","journal-title":"Clin Infect Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1093\/cid\/ciw328","article-title":"The Veterans Aging Cohort Study (VACS) index and neurocognitive change: a longitudinal study","volume":"63","author":"Marquine","year":"2016","journal-title":"Clin Infect Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1097\/QAI.0000000000000341","article-title":"An adapted frailty-related phenotype and the VACS index as predictors of hospitalization and mortality in HIV-infected and uninfected individuals","volume":"67","author":"Akgun","year":"2014","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B24","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1089\/aid.2014.0225","article-title":"Short communication: the Veterans Aging Cohort Study Index is an effective tool to assess baseline frailty status in a contemporary cohort of HIV-infected persons","volume":"31","author":"Escota","year":"2015","journal-title":"AIDS Res Hum Retroviruses."},{"key":"B25","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s13365-015-0411-6","article-title":"The impact of ethnicity\/race on the association between the Veterans Aging Cohort Study (VACS) Index and neurocognitive function among HIV-infected persons","volume":"22","author":"Marquine","year":"2016","journal-title":"J Neurovirol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1093\/infdis\/jiu254","article-title":"Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment","volume":"210","author":"Tenorio","year":"2014","journal-title":"J Infect Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.molimm.2004.06.017","article-title":"Neopterin in HIV-1 infection","volume":"42","author":"Wirleitner","year":"2005","journal-title":"Mol Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1089\/aid.2014.0004","article-title":"Galectin-9 is rapidly released during acute HIV-1 infection and remains sustained at high levels despite viral suppression even in elite controllers","volume":"30","author":"Tandon","year":"2014","journal-title":"AIDS Res Hum Retroviruses."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1093\/cid\/cix600","article-title":"Interferon-gamma-Inducible Protein 10 (IP-10) as a screening tool to optimize human immunodeficiency virus RNA monitoring in resource-limited settings","volume":"65","author":"Pastor","year":"2017","journal-title":"Clin Infect Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"9186940","DOI":"10.1155\/2018\/9186940","article-title":"The role of galectins as modulators of metabolism and inflammation","volume":"2018","author":"Brinchmann","year":"2018","journal-title":"Mediators Inflamm."},{"key":"B31","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.cytogfr.2011.06.001","article-title":"CXCL10\/IP-10 in infectious diseases pathogenesis and potential therapeutic implications","volume":"22","author":"Liu","year":"2011","journal-title":"Cytokine Growth Factor Rev."},{"key":"B32","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3390\/antiox7070080","article-title":"Neopterin, inflammation, and oxidative stress: what could we be missing?","volume":"7","author":"Gieseg","year":"2018","journal-title":"Antioxidants."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e1005677","DOI":"10.1371\/journal.ppat.1005677","article-title":"Human Galectin-9 Is a potent mediator of HIV transcription and reactivation","volume":"12","author":"Abdel-Mohsen","year":"2016","journal-title":"PLoS Pathog."},{"key":"B34","doi-asserted-by":"publisher","first-page":"10650","DOI":"10.1073\/pnas.1017954108","article-title":"Galectin-9 binding to cell surface protein disulfide isomerase regulates the redox environment to enhance T-cell migration and HIV entry","volume":"108","author":"Bi","year":"2011","journal-title":"Proc Natl Acad Sci USA."},{"key":"B35","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.virol.2007.09.034","article-title":"Galectin-1 promotes HIV-1 infectivity in macrophages through stabilization of viral adsorption","volume":"371","author":"Mercier","year":"2008","journal-title":"Virology."},{"key":"B36","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.virusres.2018.11.012","article-title":"Galectin-3 is involved in HIV-1 expression through NF-kappaB activation and associated with Tat in latently infected cells","volume":"260","author":"Okamoto","year":"2019","journal-title":"Virus Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"4120","DOI":"10.4049\/jimmunol.174.7.4120","article-title":"Galectin-1 acts as a soluble host factor that promotes HIV-1 infectivity through stabilization of virus attachment to host cells","volume":"174","author":"Ouellet","year":"2005","journal-title":"J Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"11742","DOI":"10.1128\/JVI.05351-11","article-title":"Host-soluble galectin-1 promotes HIV-1 replication through a direct interaction with glycans of viral gp120 and host CD4","volume":"85","author":"St-Pierre","year":"2011","journal-title":"J Virol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1093\/glycob\/cwu064","article-title":"Galectin-3 promotes HIV-1 budding via association with Alix and Gag p6","volume":"24","author":"Wang","year":"2014","journal-title":"Glycobiology."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1373\/clinchem.2009.127084","article-title":"Neopterin and cardiovascular disease: growing evidence for a role in patient risk stratification","volume":"55","author":"Avanzas","year":"2009","journal-title":"Clin Chem."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1681\/ASN.2014010093","article-title":"Galectin-3, renal function, and clinical outcomes: results from the LURIC and 4D studies","volume":"26","author":"Drechsler","year":"2015","journal-title":"J Am Soc Nephrol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/jgh.13851","article-title":"Correlation between serum galectin-9 levels and liver fibrosis","volume":"33","author":"Fujita","year":"2018","journal-title":"J Gastroenterol Hepatol."},{"key":"B43","first-page":"669","article-title":"Galectin-3 concentration in liver diseases","volume":"45","author":"Gudowska","year":"2015","journal-title":"Ann Clin Lab Sci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1471-2369-14-23","article-title":"Serum galectin-9 levels are elevated in the patients with type 2 diabetes and chronic kidney disease","volume":"14","author":"Kurose","year":"2013","journal-title":"BMC Nephrol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.kint.2017.06.028","article-title":"Plasma galectin-3 levels are associated with the risk of incident chronic kidney disease","volume":"93","author":"Rebholz","year":"2018","journal-title":"Kidney Int."},{"key":"B46","doi-asserted-by":"publisher","first-page":"8696543","DOI":"10.1155\/2018\/8696543","article-title":"Galectin-1 as an emerging mediator of cardiovascular inflammation: mechanisms and therapeutic opportunities","volume":"2018","author":"Seropian","year":"2018","journal-title":"Mediators Inflamm."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2478\/jomb-2018-0019","article-title":"Clinical significance of increased serum neopterin in chronic kidney failure as a biomarker of cell-mediated immunity","volume":"38","author":"Unuvar","year":"2019","journal-title":"J Med Biochem."},{"key":"B48","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1146\/annurev.pharmtox.48.113006.094615","article-title":"Biomarkers of acute kidney injury","volume":"48","author":"Vaidya","year":"2008","journal-title":"Annu Rev Pharmacol Toxicol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"893106","DOI":"10.1155\/2014\/893106","article-title":"The multifaceted functions of CXCL10 in cardiovascular disease","volume":"2014","author":"van den Borne","year":"2014","journal-title":"Biomed Res Int."},{"key":"B50","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1136\/gut.37.1.108","article-title":"Serum neopterin concentrations in chronic liver disease","volume":"37","author":"Wilmer","year":"1995","journal-title":"Gut."},{"key":"B51","doi-asserted-by":"publisher","first-page":"506","DOI":"10.5009\/gnl.2011.5.4.506","article-title":"Serum IP-10 levels correlate with the severity of liver histopathology in patients infected with genotype-1 HCV","volume":"5","author":"You","year":"2011","journal-title":"Gut Liver"},{"key":"B52","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/1440-1681.13048","article-title":"The role of galectin-3 in heart failure and cardiovascular disease","volume":"46","author":"Zhong","year":"2019","journal-title":"Clin Exp Pharmacol Physiol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/QAD.0000000000002404","article-title":"Plasma inflammatory biomarkers link to diffusion tensor imaging metrics in virally suppressed HIV-infected individuals","volume":"34","author":"Chang","year":"2020","journal-title":"AIDS."},{"key":"B54","doi-asserted-by":"publisher","first-page":"e92606","DOI":"10.1371\/journal.pone.0092606","article-title":"The VACS index accurately predicts mortality and treatment response among multi-drug resistant HIV infected patients participating in the options in management with antiretrovirals (OPTIMA) study","volume":"9","author":"Brown","year":"2014","journal-title":"PLoS ONE."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1093\/infdis\/jiw263","article-title":"Plasma soluble CD163 level independently predicts all-cause mortality in HIV-1-infected individuals","volume":"214","author":"Knudsen","year":"2016","journal-title":"J Infect Dis."},{"key":"B56","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1097\/QAI.0b013e31825a3668","article-title":"HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group","volume":"60","author":"High","year":"2012","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B57","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1093\/infdis\/jiq118","article-title":"Plasma levels of soluble CD14 independently predict mortality in HIV infection","volume":"203","author":"Sandler","year":"2011","journal-title":"J Infect Dis."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1189\/jlb.3A0414-232RR","article-title":"High IP-10 levels decrease T cell function in HIV-1-infected individuals on ART","volume":"96","author":"Ramirez","year":"2014","journal-title":"J Leukoc Biol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1084\/jem.160.1.310","article-title":"Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma","volume":"160","author":"Huber","year":"1984","journal-title":"J Exp Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1159\/000023950","article-title":"Neopterin-induced tumor necrosis factor-alpha synthesis in vascular smooth muscle cells in vitro","volume":"116","author":"Hoffmann","year":"1998","journal-title":"Int Arch Allergy Immunol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0171-2985(98)80064-8","article-title":"Neopterin induces nitric oxide-dependent apoptosis in rat vascular smooth muscle cells","volume":"199","author":"Hoffmann","year":"1998","journal-title":"Immunobiology."},{"key":"B62","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.cyto.2018.11.018","article-title":"IP-10 is highly involved in HIV infection","volume":"115","author":"Lei","year":"2019","journal-title":"Cytokine."},{"key":"B63","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2174\/1874613601711010024","article-title":"Plasma IP-10 concentrations correlate positively with viraemia and inversely with CD4 counts in untreated HIV infection","volume":"11","author":"Mhandire","year":"2017","journal-title":"Open AIDS J."},{"key":"B64","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.meegid.2017.11.002","article-title":"High CXCL10\/IP-10 levels are a hallmark in the clinical evolution of the HIV infection","volume":"57","author":"Valverde-Villegas","year":"2018","journal-title":"Infect Genet Evol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"476979","DOI":"10.1155\/2012\/476979","article-title":"Association between serum neopterin and inflammatory activation in chronic kidney disease","volume":"2012","author":"Yadav","year":"2012","journal-title":"Mediators Inflamm."},{"key":"B66","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1159\/000106505","article-title":"Blockade of IP-10\/CXCR3 promotes progressive renal fibrosis","volume":"107","author":"Nakaya","year":"2007","journal-title":"Nephron Exp Nephrol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s11904-019-00433-w","article-title":"Breaking the Glyco-Code of HIV persistence and immunopathogenesis","volume":"16","author":"Colomb","year":"2019","journal-title":"Curr HIV\/AIDS Rep."},{"key":"B68","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s13365-018-0696-3","article-title":"Elevated cerebrospinal fluid Galectin-9 is associated with central nervous system immune activation and poor cognitive performance in older HIV-infected individuals","volume":"25","author":"Premeaux","year":"2019","journal-title":"J Neurovirol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3389\/fimmu.2019.00267","article-title":"Galectin-9 Mediates HIV Transcription by Inducing TCR-Dependent ERK Signaling","volume":"10","author":"Colomb","year":"2019","journal-title":"Front Immunol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/1742-4690-10-74","article-title":"Dysregulated Tim-3 expression on natural killer cells is associated with increased Galectin-9 levels in HIV-1 infection","volume":"10","author":"Jost","year":"2013","journal-title":"Retrovirology."},{"key":"B71","doi-asserted-by":"publisher","first-page":"e95061","DOI":"10.1371\/journal.pone.0095061","article-title":"Adjudicated morbidity and mortality outcomes by age among individuals with HIV infection on suppressive antiretroviral therapy","volume":"9","author":"Miller","year":"2014","journal-title":"PLoS ONE."},{"key":"B72","doi-asserted-by":"publisher","first-page":"19482","DOI":"10.7448\/IAS.17.4.19482","article-title":"Determinants of IL-6 levels during HIV infection","volume":"17","author":"Borges","year":"2014","journal-title":"J Int AIDS Soc."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1097\/QAD.0b013e32835f6b0c","article-title":"Predicting risk of cancer during HIV infection: the role of inflammatory and coagulation biomarkers","volume":"27","author":"Borges","year":"2013","journal-title":"AIDS."},{"key":"B74","doi-asserted-by":"publisher","first-page":"e44454","DOI":"10.1371\/journal.pone.0044454","article-title":"Inflammation, coagulation and cardiovascular disease in HIV-infected individuals","volume":"7","author":"Duprez","year":"2012","journal-title":"PLoS ONE."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1097\/QAD.0b013e32833ad914","article-title":"Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infection","volume":"24","author":"Ford","year":"2010","journal-title":"AIDS."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1097\/QAD.0000000000000320","article-title":"Is bone loss linked to chronic inflammation in antiretroviral-naive HIV-infected adults? A 48-week matched cohort study","volume":"28","author":"Hileman","year":"2014","journal-title":"AIDS."},{"key":"B77","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1097\/QAD.0b013e3283453fcb","article-title":"Markers of endothelial dysfunction, coagulation and tissue fibrosis independently predict venous thromboembolism in HIV","volume":"25","author":"Musselwhite","year":"2011","journal-title":"AIDS."},{"key":"B78","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1210\/jc.2006-2190","article-title":"Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease","volume":"92","author":"Triant","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1093\/infdis\/jix518","article-title":"Comorbidities among US patients with prevalent HIV infection-A trend analysis","volume":"216","author":"Gallant","year":"2017","journal-title":"J Infect Dis."},{"key":"B80","doi-asserted-by":"publisher","first-page":"e0118531","DOI":"10.1371\/journal.pone.0118531","article-title":"Aging with HIV vs. HIV seroconversion at older age: a diverse population with distinct comorbidity profiles","volume":"10","author":"Guaraldi","year":"2015","journal-title":"PLoS ONE."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1093\/cid\/ciu701","article-title":"Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study","volume":"59","author":"Schouten","year":"2014","journal-title":"Clin Infect Dis."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1093\/cid\/cir626","article-title":"Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study","volume":"53","author":"Hasse","year":"2011","journal-title":"Clin Infect Dis."},{"key":"B83","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41574-018-0059-4","article-title":"Inflammaging: a new immune-metabolic viewpoint for age-related diseases","volume":"14","author":"Franceschi","year":"2018","journal-title":"Nat Rev Endocrinol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1097\/QAD.0b013e32801022eb","article-title":"Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review","volume":"20","author":"Brown","year":"2006","journal-title":"AIDS."},{"key":"B85","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/j.1523-1755.2005.67096.x","article-title":"HAART-related nephropathies in HIV-infected patients","volume":"67","author":"Daugas","year":"2005","journal-title":"Kidney Int."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1056\/NEJMoa030218","article-title":"Combination antiretroviral therapy and the risk of myocardial infarction","volume":"349","author":"Friis-Moller","year":"2003","journal-title":"N Engl J Med."},{"key":"B87","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.bbalip.2009.09.018","article-title":"Drug-induced lipotoxicity: lipodystrophy associated with HIV-1 infection and antiretroviral treatment","volume":"1801","author":"Villarroya","year":"2010","journal-title":"Biochim Biophys Acta."},{"key":"B88","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1506816","article-title":"Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection","volume":"373","author":"Group","year":"2015","journal-title":"N Engl J Med."},{"key":"B89","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1097\/QAD.0000000000001417","article-title":"Improved quality of life with immediate versus deferred initiation of antiretroviral therapy in early asymptomatic HIV infection","volume":"31","author":"Lifson","year":"2017","journal-title":"AIDS."},{"key":"B90","doi-asserted-by":"publisher","first-page":"e553","DOI":"10.1016\/S2352-3018(18)30214-5","article-title":"Vorapaxar for HIV-associated inflammation and coagulopathy (ADVICE): a randomised, double-blind, placebo-controlled trial","volume":"5","author":"group","year":"2018","journal-title":"Lancet HIV."},{"key":"B91","doi-asserted-by":"publisher","first-page":"e284","DOI":"10.1016\/S2352-3018(17)30075-9","article-title":"Pitavastatin versus pravastatin in adults with HIV-1 infection and dyslipidaemia (INTREPID): 12 week and 52 week results of a phase 4, multicentre, randomised, double-blind, superiority trial","volume":"4","author":"Aberg","year":"2017","journal-title":"Lancet HIV."},{"key":"B92","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1097\/QAD.0000000000001427","article-title":"Effects of pitavastatin and pravastatin on markers of immune activation and arterial inflammation in HIV","volume":"31","author":"Toribio","year":"2017","journal-title":"AIDS."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1093\/cid\/ciy781","article-title":"Safety and impact of low-dose methotrexate on endothelial function and inflammation in individuals with treated human immunodeficiency virus: AIDS clinical trials group study A5314","volume":"68","author":"Hsue","year":"2019","journal-title":"Clin Infect Dis."},{"key":"B94","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1089\/aid.2015.0336","article-title":"The effect of chloroquine on immune activation and interferon signatures associated with HIV-1","volume":"32","author":"Jacobson","year":"2016","journal-title":"AIDS Res Hum Retroviruses."},{"key":"B95","doi-asserted-by":"publisher","first-page":"12082","DOI":"10.1128\/JVI.01466-10","article-title":"Reduction of immune activation with chloroquine therapy during chronic HIV infection","volume":"84","author":"Murray","year":"2010","journal-title":"J Virol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"ofw278","DOI":"10.1093\/ofid\/ofw278","article-title":"A randomized placebo controlled trial of aspirin effects on immune activation in chronically human immunodeficiency virus-infected adults on virologically suppressive antiretroviral therapy","volume":"4","author":"O'Brien","year":"2017","journal-title":"Open Forum Infect Dis."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1093\/infdis\/jiy064","article-title":"Telmisartan therapy does not improve lymph node or adipose tissue fibrosis more than continued antiretroviral therapy alone","volume":"217","author":"Utay","year":"2018","journal-title":"J Infect Dis."},{"key":"B98","doi-asserted-by":"publisher","first-page":"6048","DOI":"10.2174\/1381612820666140317110217","article-title":"Activated immune system and inflammation in healthy ageing: relevance for tryptophan and neopterin metabolism","volume":"20","author":"Capuron","year":"2014","journal-title":"Curr Pharm Des."},{"key":"B99","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1093\/gerona\/glq066","article-title":"Serum levels of the immune activation marker neopterin change with age and gender and are modified by race, BMI, and percentage of body fat","volume":"65","author":"Spencer","year":"2010","journal-title":"J Gerontol A Biol Sci Med Sci."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01321\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T04:49:52Z","timestamp":1593492592000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01321\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,30]]},"references-count":99,"alternative-id":["10.3389\/fimmu.2020.01321"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.01321","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,30]]},"article-number":"1321"}}